4//SEC Filing
SCHEIBLER LUKAS 4
Accession 0001127602-23-001500
CIK 0001492422other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 7:42 PM ET
Size
6.9 KB
Accession
0001127602-23-001500
Insider Transaction Report
Form 4
SCHEIBLER LUKAS
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-01-12$52.66/sh+35,472$1,867,956→ 35,472 totalExercise: $52.66Exp: 2033-01-11→ Common Stock (35,472 underlying) - Award
Common Stock
2023-01-12+22,580→ 63,707 total
Footnotes (3)
- [F1]This represents a Restricted Stock Award granted 01/12/23 that vest annually from grant date over a four year period subject to continued service.
- [F2]This includes 769 shares from 04/29/2022 ESPP purchase.
- [F3]This represents a stock option award granted 01/12/2023 that vest over a four year period. 25% vest one year from grant date and the remaining 75% vest monthly thereafter subject to continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001651281
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 7:42 PM ET
- Size
- 6.9 KB